At IDT Biologika, we are committed to your development and manufacturing needs for innovative vaccines, cell & gene therapeutics from early stage of process development to clinical trial materials and commercial manufacturing. We offer clients a single source CDMO partner at our sites in Germany and the USA, with seamless end-to-end solutions and the ability to nimbly scale projects from development through to commercialization. This includes Process Development, Drug Substance Manufacturing, Sterile Dosage Fill-Finish, Labelling & Packaging, Quality Control & Analytics. With more than 100 years of expertise in vaccine manufacturing we are redefining the boundaries of innovation in commercial manufacturing for our clients. We expanded our fill-finish capacities for large molecule products (including RNA) by setting-up another aseptic high-speed filling line. Also building upon our industry leading knowledge of virus and viral vectors, we help you to overcome challenges with your products by defining the appropriate technologies and experience to define a process that works best and can be scaled. IDT Biologika’s next generation AAV and LV platforms expand on the company’s success and partnerships with our clients. Having produced one of the first CGT products approved by the FDA and EMA, we strive to bring the next generation of therapeutics to market.